Histopathological features of HER2 overexpression in uterine carcinosarcoma: proposal for requirements in HER2 testing for targeted therapy
Sign Up to like & getrecommendations! Published in 2021 at "Virchows Archiv"
DOI: 10.1007/s00428-021-03017-5
Abstract: Uterine carcinosarcoma (UCS) is an uncommon and highly aggressive tumor. There is no HER2 testing protocol for UCS despite the development of HER2 antibody conjugates. We aimed to elucidate histopathological HER2 expression details in UCS,… read more here.
Keywords: her2 testing; features her2; uterine carcinosarcoma; histopathological features ... See more keywords
Clinical-pathological features in HER2-positive advanced gastric cancer: Italian data of the Reggio Emilia Clinical Cancer Centre.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e16067
Abstract: e16067Background: HER2 is an important biomarker in advanced gastric cancer (GC). Adding trastuzumab to chemotherapy (CHT) improved survival in patients with metastatic GC with overexpression of HE... read more here.
Keywords: advanced gastric; gastric cancer; pathological features; features her2 ... See more keywords